| |
|
| |
|
| |
|
| |
|
| |
March 30, 2007，Hall 1 |
| |
Drug-Eluting Stent: State of the Art |
| |
Sponsored by MicroPort |
| |
Moderators |
Junbo Ge
Shuzheng Lu
Jiyan Chen
Liliana R. Grinfeld
Yaron Almagor |
| |
|
| |
12:15 PM - Final Clinical and Angiographic
Results From a Nationwide Registry of
FIREBIRD Sirolimus-Eluting Stent:
Firebird In China (FIC) Registry
Runlin Gao
Interpreter Jie Qian
12:30 PM - A Prospective, Multicenter, FIM
Study of Second Generation Sirolimus
Eluting Cobalt Alloyed IREBIRD 2 Stent:
6-Month Angiographic and IVUS Results,
and 1-Year Clinical utcomes
Weifeng Shen
Interpreter Qi Zhang
12:45 PM - An Overview of the Latest
Approach to Bifurcation Lesion
Yaron Almagor
Interpreter Jian Liu
1:00 PM - Moderated Q&A Roundtable
Discussion
1:12 PM - Conclusion
1:15 PM - Adjourn |
| |
|
| |
|
| |
March 31, 2007，Hall 17 |
| |
Sponsored by JW Medical |
| |
Moderators |
Runlin Gao
Yuejin Yang
Shuzheng Lu |
| |
|
| |
12:15 PM - Introduction
12:20 PM - Twelve-Month Clinical,
Angiographic and IVUS Follow-up Results
From EXCEL CREATE Pilot Study
Yaling Han
12:35 PM - Current Status and
Development of Drug-Eluting Stent
Eberhard Grube
12:50 PM - Two-Year Follow-up Results of EXCEL First-in-Man Clinical Study
Teguh Santoso
1:05 PM - Moderated Q&A Roundtable
Discussion
1:15 PM - Adjourn
|
| |
|
| |
|
| |
|
| |
|
| |
March 29, 2007，Hall 2 |
| |
Focus 2007 Global Hotspots: New Antithrombotic Strategies in PCI |
| |
Sponsored by Sanofi-Aventis |
| |
Moderators |
Runlin Gao
Yong Huo |
| |
|
| |
12:00 PM - From Guideline to Practice:
The Clinical Management of PCI
Runlin Gao
12:25 PM - Prevention of Late Stent
Thrombosis Post-PCI
Yong Huo
12:50 PM - New Insight into
Anticoagulation in PCI
Yundai Chen
1:15 PM - Panel Discussion and Q&A
1:20PM - Conclusion
1:30 PM - Adjourn |
| |
|
| |
|
| |
March 30, 2007，Hall 2 |
| |
Comprehensive Prevention Strategy of Cardiovascular Disease |
| |
Sponsored by Bayer |
| |
Moderators |
Runlin Gao
Yaling Han |
| |
|
| |
12:15 PM - Postprandial Hyperglycemia in Cardiovascular Complication
Dajin Zou
12:40 PM - The Clinical Strategy on Platelet Aggregation Inhibitor
Shuyang Zhang
1:05 PM - Moderated Q&A Roundtable Discussion
1:15 PM - Conclusion
1:20 PM - Adjourn |
| |
|
| |
|
| |
March 30, 2007，Hall 6 |
| |
Sponsored by Lepu Medical |
| |
Moderators |
Zhanquan Li
Jianhua Zhu
Ben He
Qiangsun Zheng |
| |
|
| |
12:15 PM - Long-term Safety and Clinical
Strategy on Drug Eluting Stent
Shubin Qiao
12:35 PM - The State-of-the-art in New
DES Research
Yong Huo
12:55 PM - Latest Research and
Development of LEPU Nano Polymer-free
DES
Ming Yang
1:15 PM - Conclusion
1:20 PM - Adjourn
|
| |
|
| |
|
| |
March 30, 2007，Hall ７ |
| |
Sponsored by JW Medical |
| |
Moderators |
Jilin Chen
Weimin Wang |
| |
|
| |
12:15 PM - Introduction
12:20 PM - The Advantage of
Biodegradable Polymer-Based
Drug-Eluting Stent
Juying Qian
12:35 PM - Common Problems and
Treatment Strategies in Emergent PCI for
STEMI
Hongbing Yan
12:50 PM - Treatment of Bifurcation Lesion
in TRI
Xueqi Li
1:05 PM - Panel Discussion and Q&A
1:15 PM - Adjourn
|
| |
|
| |
|
| |
March 30, 2007，Hall 8 |
| |
CTO Approach: Get Beyond the Limitation
Sponsored by Terumo |
| |
Moderators |
Yuejin Yang
Ben He
Zhimin Du |
| |
12:15 PM - CART (Controlled Antegrade
and Retrograde Subintimal Tracking) Wire
Technique
Shigeru Saito
12:35 PM - Treatment of Complex CTO
Lesions
Yuejin Yang
12:55 PM - The Key Tips of CTO
Treatment
Weimin Li
1:15 PM - Conclusion
1:20 PM - Adjourn |
| |
|
| |
|
| |
March 30, 2007，Hall 17A |
| |
Key Issues Had to Be Concerned in the
Era of DES |
| |
Sponsored by Abbott Vascular |
| |
Moderators |
Shubin Qiao
Haichang Wang |
| |
|
| |
12:15 PM - The Importance of Pre- and
Post- Dilatation in the Era of DES
Yundai Chen
12:30 PM - Will DES Totally Replace BMS
in All Patient/Lesion Subsets? - The
Indication of BMS Usage in the Era of
DES
Weimin Wang
12:45 PM - Case Presentation 1
Lijun Guo
12:55 PM - Case Presentation 2
Xuebo Liu
1:05 PM - Panel Discussion and Q&A
1:15 PM - Adjourn
|
| |
|
| |
|
| |
March 30, 2007，Hall 17B |
| |
The Update of AFIB Catheter Ablation
and China Experience |
| |
Sponsored by Cordis,
A Johnson & Johnson Company |
| |
Moderator |
Shu Zhang |
| |
|
| |
12:15 PM - Update in Boston AFIB
Symposium 1
Changsheng Ma
12:30 PM - Update in Boston AFIB
Symposium 2
Jian Ma
12:45 PM - Success and Issues in Clinical Application of AFIB Ablation in China
Congxin Huang
1:05 PM - Moderated Q&A Roundtable
Discussion
1:10 PM - Conclusion
1:15 PM - Adjourn |
| |
|
| |
|
| |
March 31, 2007，Hall 2 |
| |
A Story of the First China-Made
Drug-Eluting Stent: Growing Evidence
of FIREBIRD |
| |
Sponsored by MicroPort |
| |
Moderators |
Weimin Wang
Shubin Qiao
Weiyi Fang |
| |
|
| |
12:15 PM - Angiographic Follow-up
Results of FIREBIRD DES From a Large
Single Center Database: omparison with
Other Workhorse DESs in All Complex
Lesion Subsets
Bo Xu
12:30 PM - Final Angiographic and
Long-term Clinical Results From a Single
Center, Randomized Study of IREBIRD
DES Versus BMS in AMI: Update on
FIBISTEMI Trial
Hongbing Yan
12:45 PM - A Prospective, Multicenter
Study of FIREBIRD Sirolimus-Eluting
Stent in the Treatment of Complex
Coronary Artery Disease: Update on
FIREMAN Registry
Haichang Wang
1:00 PM - Moderated Q&A Roundtable
Discussion
1:12 PM - Conclusion 1:15 PM - Adjourn |
| |
|
| |
|
| |
March 31, 2007，Hall 6 |
| |
Experience Innovation from SIEMENS
Sponsored by SIEMENS |
| |
Moderators |
Kejiang Cao
Jiyan Chen |
| |
|
| |
12:15 PM - Current Status and Prospect:
The Applications of Angiographic CT in
Intervention
K. Klingenbeck
12:35 PM - The Advanced Applications of
Cutting-edge Dual Source CT in Cardiac
Intervention
Zhengyu Jin
12:55 PM - Advanced MR Application in
Coronary Heart Disease
Shihua Zhao
1:15 PM - Panel Discussion and Q&A
1:20 PM - Adjourn |
| |
|
| |
|
| |
March 31, 2007，Hall 7 |
| |
Right Time, Right Devices! |
| |
Sponsored by Medtronic |
| |
Moderators |
Jilin Chen
Jiyan Chen |
| |
|
| |
12:15 PM - Introduction
12:20 PM - Guiding Selection for Complex Lesion during PCI
Yujie Zhou
12:35 PM - New Choice of Workhorse Wire in Daily Practice
Lefeng Wang
12:50 PM - The Necessity of GuardWire EPD System during SVG and AMI Intervention
Hongbing Yan
1:05 PM - Moderated Q&A Roundtable Discussion
1:12 PM - Conclusion
1:15 PM - Adjourn |
| |
|
| |
|
| |
March 31, 2007,
Hall 8 |
| |
Cardiac Intervention in Complex Lesions |
| |
Sponsored by St. Jude Medical (Shanghai) Ltd. |
| |
Moderators |
Jiyan Chen
Weimin Wang
Juying Qian |
| |
|
| |
12:15 PM - Venture Wire Control Catheter Application in Challenging cases
Jianfang Luo
12:40 PM - An innovative tool for treating Challenging Cases
Jian Liu
1:05 PM - Panel Discussion and Q&A
1:10 PM - Conclusion
1:15 PM - Adjourn |
| |
|
| |
|
| |
March 31, 2007，Hall 17A |
| |
Sponsored by Pfizer |
| |
Moderators |
Weifeng Shen
Yong Huo |
| |
|
| |
12:15 PM - Strategies of Lipid-Lowering Therapy for High Risk Patients
Ben He
12:45 PM - Optimal Anticoagulation Therapy for ACS Patients with Mild to Moderate Renal Failure
Yundai Chen
1:15 PM - Panel Discussion and Q&A
1:20 PM - Adjourn |
| |
|
| |
|
| |
March 31, 2007，Hall 17B |
| |
Challenging Case Review from
OLYMPIA in China |
| |
Sponsored by Boston Scientific |
| |
Moderators |
Meng Wei
Yawei Xu |
| |
|
| |
12:10 PM - Case Presentation 1
Hongliang Cong
12:15 PM - Case Presentation 2
Lei Ge
12:20 PM - Discussion
12:28 PM - Case Presentation 3
Wenyi Guo
12:33 PM - Case Presentation 4
Ben He
12:38 PM - Discussion
12:46 PM - Case Presentation 5
Tianchang Li
12:51 PM - Case Presentation 6
Shouli Wang
12:56 PM - Discussion
1:04 PM - Case Presentation 7
Qinzhu Wen
1:09 PM - Case Presentation 8
Shangyu Wen
1:14 PM - Discussion
1:22 PM - Conclusion
1:25 PM - Adjourn
|
| |
|
| |
|
| |
April 1,2007,Hall 7 |
| |
Pay Close Attention to Clinical Data on
Interventional Cardiology |
| |
Jointly Sponsored by CCHEART
Review and MSD HCN |
| |
Moderator |
Bo Xu |
| |
Discussants |
Yundai Chen
Lei Ge
Lang Li
Jian Liu |
| |
|
| |
12:15 PM - From Evidence-based
Medicine to Clinical Practice: Pay Close
Attention to Clinical Data on Interventional
Cardiology!
Jian Liu
Flash Debate 1 - To Think or to Act
12:30 PM - Action First, then Update Mind!
Jianxiong Liu
12:35 PM - Update Mind First, and then
Action!
Shaoping Chen
12:40 PM - Panel Discussion and
Audience Response
Flash Debate 2 - How to Collect and Save
Effective Clinical Data
12:50 PM - Clinical Follow-up Is NOT
Equal to Daily Out-patient Clinic
Jie Song
12:55 PM - Daily Out-patient Clinic Is
Approximately Equal to Clinical Follow-up
Xiantao Song
1:00 PM - Panel Discussion and
Audience Response
1:10 PM - The Value of Clinical Data on
Interventional Cardiology and Challenge in
Reality
Lei Ge
1:22 PM - Conclusion
1:25 PM - Adjourn |
| |
|
| |
|
| |
April 1,2007,Hall 8 |
| |
How to Prevent the In-hospital Cardiac and Renal Complications in High-risk PCI Patients? |
| |
Sponsored by GE Healthcare |
| |
Moderators |
Guoying Zhu
Weifeng Shen |
| |
12:15 PM - The Latest PCI Strategy in
Patient with Renal Dysfunction
Weifeng Shen
12:35 PM - Contrast-induced Nephropathy
(CIN): The Fateful Weakness in PCI
Jiyan Chen
12:55 PM - Contrast Media and
Thrombosis: The More We Know, the
More We Need to Know
Yujie Zhou
1:15 PM - Panel Discussion and Q&A
1:20 PM - Adjourn |
| |
|
| |
|
| |
Evening Satellite Symposium |
| |
|
| |
March 30, 2007，Hall 2 |
| |
Safety First! |
| |
Sponsored by Medtronic |
| |
Moderators |
Runlin Gao
Yong Huo
Shuzheng Lu
Bo Xu |
| |
|
| |
6:00 PM - Introduction
6:10 PM - Endeavor Clinical Program
Update
Martin B. Leon
Interpreter Liu, Jian
6:35 PM - Making Practical Clinical Sense
of All the Data in this DES Era
Spencer B. King III
Interpreter Liu, Jian
7:00 PM - Real World Experience of DES
in China
Junbo Ge
7:20 PM - Moderated Q&A Roundtable Discussion
7:25 PM - Conclusion 7:30 PM - Adjourn |
| |
|
| |
|
| |
March 30, 2007，Hall 17 |
| |
TAXUS – What We Can Learn From You
for the Next Generation DES? |
| |
Sponsored by Boston Scientific |
| |
Moderators |
Jiyan Chen
Yuejin Yang
Guoying Zhu |
| |
Interpreter |
Yi Li |
| |
|
| |
6:00 PM - Introduction
6:05 PM - Delivering What We Have
Learned So Far
Gregg W. Stone
6:30 PM - TAXUS in Treating Unprotected
Left Main Coronary Artery Disease
Yaling Han
6:55 PM - IVUS Findings Across TAXUS
Clinical Programs
Gary S. Mintz
7:20 PM - Moderated Q&A Roundtable
Discussion
7:27 PM - Conclusion
7:30 PM - Adjourn |
| |
|
| |
|
| |
March 31, 2007，Hall 2 |
| |
Treatment of Complex Lesions and the
Safety of CYPHER from the
Evidence-based Medicine Perspective |
| |
Sponsored by Cordis,
A Johnson & Johnson Company |
| |
Moderators |
Jilin Chen
Zhimin Du
Yong Huo |
| |
|
| |
6:00 PM - Techniques and Evidence in
Treating Complex Lesions
Antonio Colombo
Interpreter Yu Wang
6:40 PM - Evaluation on the Safety Profile
of CYPHER DES
Yean-Leng Lim
7:00 PM - Paradoxes and Perplexities in
PCI
Shuzheng Lu
7:20 PM - Moderated Q&A and Discussion
7:30 PM - Adjourn |
| |
|
| |
|
| |
March 31, 2007，Hall 17 |
| |
Xience V Everolimus-Eluting Stent: Beyond Targeting Restenosis! |
| |
Sponsored by Abbott Vascular |
| |
Moderator |
Runlin Gao |
| |
Co-oderators |
Jiyan Chen
Junbo Ge
Yuejin Yang |
| |
Interpreter |
Jian Liu |
| |
|
| |
6:00 PM - Introduction
6:05 PM - The Science Behind Xience V——
SPIRIT III: 9-Month Results of the US
Pivotal Trial
Gregg W. Stone
6:30 PM - Comparison of First and Second
Generation DES——From Preclinical to
Clinical
Mitchell W. Krucoff
6:50 PM - ABSORB: 6-Month Results of
First-in-Man Registry Study With the
Bioabsorbable Everolimus-Eluting Stent
Patrick W. Serruys
7:10 PM - Panel Discussion and Q&A
7:25 PM - Conclusion 7:30 PM - Adjourn |
| |
|
| |
|
| |
|
| |
|
│General Information│Live Case Sites│Case review│Abstract review